Psychometric evaluation of the Arabic Version the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20)

It’s never too late - balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: results of a randomized controlled trial

(2019) S. Kneis et al.   BMC CANCER

Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Ca

(2018) Hui Lin Cheng et al.   Asia-Pacific Journal of Clinical Oncology

Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data

(2018) Ellen M. Lavoie Smith et al.   CANCER NURSING

Reliability and Validity of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to Assess Chemotherapy-induced Peripheral Neuropathy

(2015) Hye Young Kim et al.   Journal of Korean Academy of Nursing

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

(2012) G. Cavaletti et al.   ANNALS OF ONCOLOGY

Validation of the Arabic version of the EORTC quality of life questionnaire among cancer patients in Lebanon

(2012) Huda Abu-Saad Huijer et al.   QUALITY OF LIFE RESEARCH

Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties

(2010) Kathleen A. Griffith et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM